Results 31 to 40 of about 244 (45)

Evaluating the Older Patient with Cancer: Understanding Frailty and the Geriatric Assessment

Ca-A Cancer Journal for Clinicians, 2010
Sumanta K Pal, Vani Katheria, Arti Hurria   +2 more
exaly  

Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis

Lancet, The, 2020
Mauro Chiarito, Francesco Cannata, Davide Cao   +2 more
exaly  

Fungal secondary metabolism — from biochemistry to genomics

Nature Reviews Microbiology, 2005
Nancy P Keller
exaly  

Regulation of fungal secondary metabolism

Nature Reviews Microbiology, 2012
Axel A Brakhage
exaly  

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

Lancet, The, 2011
Salim Yusuf, Shofiqul Islam, Sumathy Rangarajan   +2 more
exaly  

Elliptic curves over real quadratic fields are modular

Inventiones Mathematicae, 2014
Nuno Freitas, Samir Siksek
exaly  

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2014
Nadine Schuerer, David MacManus, Charles R M Bangham   +2 more
exaly  

Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth

Lancet, The, 2008
Roberto Romero, Robert L Goldenberg
exaly  

Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial

Lancet, The, 2019
Gholamreza Roshandel, Masoud Khoshnia, Hossein Poustchi   +2 more
exaly  

Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis

Lancet, The, 1998
Ludwig Kappos
exaly